Open figure viewer
References
1.
Shahani R, Streutker C, Dickson B, Stewart RJ: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 2007;69:810–812.
2.
Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JM, Lau FL, Yiu MK, Man CW: The destruction of the lower urinary tract by ketamine abuse: a new syndrome. BJU Int 2008;102:1616–1622.
3.
Mason K, Cottrell AM, Corrigan AG, Gillatt DA, Mitchelmore AE: Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin Radiol 2010;65:795–800.
4.
Meng E, Chang HY, Chang SY, Sun GH, Yu DS, Cha TL: Involvement of purinergic neurotransmission in ketamine-induced bladder dysfunction. J Urol 2011;186:1134–1141.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
You do not currently have access to this content.
